Prostate Cancer Campaigns Boost Enrollment in Study to Validate ClarityDX Diagnostic Test in Canada

Prostate Cancer Campaigns Boost Enrollment in Study to Validate ClarityDX Diagnostic Test in Canada
Campaigns by Movember and the Alberta Cancer Foundation have helped to raise the number of men enrolled to more than 200 in the validation study of ClarityDX Prostate, a new blood screening test developed by Nanostics for the early diagnosis of prostate cancer. Recruitment, which started in June this year, got an additional boost in November, thanks to the "Grow a Mo" (moustache) and GivingTuesday 2019 campaigns run by the two Canadian charities. "We are overwhelmed by the support we've received from people all over Alberta as we work to validate the ClarityDX Prostate test," John Lewis, Sojonky chair in
Subscribe or to access all post and page content.